London Infection Trainees Regional Training Day in Antimicrobial Resistance
23 October 2024
Royal Society of Medicine, 1 Wimpole Street, London
Recorded content from this event can be accessed below.
Organised by Dr Emma McGuire, Dr Ioannis Baltas and Dr Ana Lima Soares.
Supported by the British Society for Antimicrobial Chemotherapy
Sponsored by Tillotts Pharma, Eumedica Pharma, Napp Pharmaceuticals Ltd, Shionogi & Co Ltd.
This meeting is sponsored by the companies through purchase of exhibition stand space.
They have not had any input into the content, speakers or the agenda.
Not yet a BSAC member? Membership is free JOIN HERE now
Programme
Session 1
-
-
Opening remarks
Dr Emma McGuire, Specialist registrar in Infectious Diseases & Medical Microbiology, University College London Hospitals NHS Foundation Trust - View Bio
Dr Ioannis Baltas, ST4 Infectious Diseases & Medical Microbiology, London Deanery - View Bio
Dr Ana Lima Soares, Specialist Doctor in Medical Microbiology, University College London Hospitals NHS Foundation Trust, London - View Bio
-
Epidemiology of AMR in England
Dr Colin Brown, Infectious Disease & Medical Microbiology Consultant, Royal Free Hospital London - View Bio
-
AMR in lower and middle income countries
Dr Alexander Aiken, Infectious Disease & Microbiology Consultant, Imperial College Healthcare NHS Trust - View Bio
-
AMR in Clostridioides difficile infection
Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust - View Bio
Session 2
-
-
Laboratory aspects of AMR
Dr Katie Hopkins, Lead Clinical Scientist, Antimicrobial Resistance & Mechanisms Service, UKHSA - View Bio
-
Interpretative reading of antibiograms
David Livermore, Retired Professor of Medical Microbiology, University of East Anglia, Norwich, UK - View Bio
-
UK AMR National Action Plan and the NHS Antimicrobial Subscription Model
Professor Phillip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire - View Bio
Session 3
-
-
Treatment of resistant Gram-positive infections
Dr Frances Davies, Consultant Microbiologist & Honorary Clinical Senior Lecturer, Imperial College Healthcare NHS Trust - View Bio
-
Treatment of resistant Gram-negative infections
Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio
-
What is the role of colistin in the era of multidrug antimicrobial resistance
Professor George L. Daikos, Professor Emeritus, National and Kapodistrian University of Athens - View Bio
Session 4
-
-
Treatment of resistant sexually transmitted infections
Dr Helen Fifer, Consultant Microbiologist, UK Health Security Agency - View Bio
-
Optimal treatment durations: Shorter is better?
Mr Steven Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Hospital NHS Foundation Trust - View Bio
-
Therapeutic drug monitoring to optimise the treatment of resistant infections
Dr Maha Albur, Consultant in Infectious Diseases & Medical Microbiology, North Bristol NHS Trust - View Bio
-
Closing remarks
Dr Emma McGuire, Specialist registrar in Infectious Diseases & Medical Microbiology, University College London Hospitals NHS Foundation Trust - View Bio
Dr Ioannis Baltas, ST4 Infectious Diseases & Medical Microbiology, London Deanery - View Bio
Dr Ana Lima Soares, Specialist Doctor in Medical Microbiology, University College London Hospitals NHS Foundation Trust, London - View Bio